Alzheimer's disease (AD) is the most common type of neurodegenerative disease. Its typical pathology consists of extracellular amyloid-β (Aβ) plaques and intracellular tau neurofibrillary tangles. Mutations in the APP, PSEN1, and PSEN2 genes increase Aβ production and aggregation, and thus cause early onset or familial AD. Even with this strong genetic evidence, recent studies support AD to result from complex etiological alterations. Among them, aging is the strongest risk factor for the vast majority of AD cases: Sporadic late onset AD (LOAD). Accumulation of DNA damage is a well-established aging factor. In this regard, a large amount of evidence reveals DNA damage as a critical pathological cause of AD. Clinically, DNA damage is accumulated in brains of AD patients. Genetically, defects in DNA damage repair resulted from mutations in the BRAC1 and other DNA damage repair genes occur in AD brain and facilitate the pathogenesis. Abnormalities in DNA damage repair can be used as diagnostic biomarkers for AD. In this review, we discuss the association, the causative potential, and the biomarker values of DNA damage in AD pathogenesis.
Keywords: Alzheimer’s disease pathogenesis; DNA damage repair; DNA damage response; diagnostic biomarkers for Alzheimer disease.
Conflict of interest statement
The authors declare no conflict of interest.
Alzheimer's disease.Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
The genes associated with early-onset Alzheimer's disease.Oncotarget. 2017 Dec 15;9(19):15132-15143. doi: 10.18632/oncotarget.23738. eCollection 2018 Mar 13. Oncotarget. 2017. PMID: 29599933 Free PMC article. Review.
Modeling Alzheimer's disease in mouse without mutant protein overexpression: cooperative and independent effects of Aβ and tau.PLoS One. 2013 Nov 20;8(11):e80706. doi: 10.1371/journal.pone.0080706. eCollection 2013. PLoS One. 2013. PMID: 24278307 Free PMC article.
Modeling Alzheimer's Disease with Induced Pluripotent Stem Cells: Current Challenges and Future Concerns.Stem Cells Int. 2016;2016:7828049. doi: 10.1155/2016/7828049. Epub 2016 May 24. Stem Cells Int. 2016. PMID: 27313629 Free PMC article. Review.
Molecular and Cellular Basis of Neurodegeneration in Alzheimer's Disease.Mol Cells. 2017 Sep 30;40(9):613-620. doi: 10.14348/molcells.2017.0096. Epub 2017 Sep 20. Mol Cells. 2017. PMID: 28927263 Free PMC article. Review.